DudeDiligence.

THE WIRE

What insiders and companies just did: insiders buying and selling with their own money, company news, new 5% stakes and new shares registered.

BoughtSoldSold under a plan set in advanceCompany newsA 5% stakeNew shares registeredThe stock since the filing

Key

BoughtSoldSold under a plan set in advanceCompany newsA 5% stakeNew shares registeredThe stock since the filing

Newest first. Insider rows are open-market purchases and sales; several by one company are one row, open it for each.

  1. CRMTAmericas Carmart IncMaterial agreement.−36.3%8-K 1.01 ↗
  2. NPWRNet Power IncOfficer or director change.+7.8%8-K 5.02 ↗
  3. PEPGPepGen IncResults of operations and Regulation FD disclosure.+58.2%8-K 2.02 ↗
  4. AENTAlliance Entertainment Holding CorpShareholder vote.+3.8%8-K 5.07 ↗
  5. ASTSAST SpaceMobile, IncRegulation FD disclosure.AST SpaceMobile to supply satellites to power Japan’s sovereign direct-to-device constellation−36.9%8-K 7.01 ↗
  6. PMVPPMV Pharmaceuticals, IncResults of operations.−29.9%8-K 2.02 ↗
  7. ALHAlliance Laundry Holdings IncResults of operations.+1.0%8-K 2.02 ↗
  8. HIVEHIVE Digital Technologies LtdResults of operations.−36.2%8-K 2.02 ↗
  9. KLRSKalaris Therapeutics, IncResults of operations.−44.3%8-K 2.02 ↗
  10. MIRMMirum Pharmaceuticals, IncOther events.+3.2%8-K 8.01 ↗
  11. MCFTMasterCraft Boat Holdings, IncResults of operations.MasterCraft Boat Holdings, Inc. Reports Results for the First Three Months of Its Transition Period+4.0%8-K 2.02 ↗
  12. ECCEagle Point Credit CoOther events.+8.0%8-K 8.01 ↗
  13. XLOXilio Therapeutics, IncResults of operations.−16.0%8-K 2.02 ↗
  14. CDXSCodexis, IncMaterial agreement and unregistered sale of shares.−9.0%8-K 1.01 ↗
  15. XGNExagen IncResults of operations.−49.2%8-K 2.02 ↗
  16. LCIILci IndustriesOther events.−2.4%8-K 8.01 ↗
  17. AMBQAmbiq Micro, IncResults of operations.Ambiq Reports Third Quarter 2026 Financial Results Third quarter net sales increased 110% year-over-year on broad demand across customers, product families and form factors Gross profit more than…−13.3%8-K 2.02 ↗
  18. ENTGEntegris IncRegulation FD disclosure and other events.Board authorizes $500 million share repurchase program−11.1%8-K 7.01 ↗
  19. ABUSArbutus Biopharma CorpResults of operations.+8.1%8-K 2.02 ↗
  20. KUSTKustom Entertainment, IncResults of operations and Regulation FD disclosure.KUSTOM ENTERTAINMENT, INC. ANNOUNCES THIRD QUARTER OPERATING RESULTS REVENUE UP 57%, NET INCOME REACHES $2.3 MILLION AND STOCKHOLDERS’ EQUITY MORE THAN TRIPLED SINCE YEAR END 2025 AS THE COMPANY…−25.4%8-K 2.02 ↗
  21. EFOIEnergy Focus, IncResults of operations.Energy Focus, Inc. Reports Third Quarter 2026 Financial Results−32.4%8-K 2.02 ↗
  22. CLRBCellectar Biosciences, IncResults of operations.−37.7%8-K 2.02 ↗
  23. AUTLAutolus Therapeutics plcResults of operations and Regulation FD disclosure.−31.3%8-K 2.02 ↗
  24. CMCCOMMERCIAL METALS CoOfficer or director change and Regulation FD disclosure.CMC Announces CFO Retirement and Succession Plan; Appoints Kenji Hashimoto as Deputy CFO−15.4%8-K 5.02 ↗
  25. CALCCalciMedica, IncResults of operations.CalciMedica Reports Third Quarter 2026 Financial Results and Provides Clinical & Corporate Updates Auxora Phase 1b proof-of-concept data in pulmonary hypertension (PH) and CM5480 IND submission both…−16.8%8-K 2.02 ↗
  26. SRRKScholar Rock Holding CorpMaterial agreement and results of operations.−6.6%8-K 1.01 ↗
  27. LNSRLENSAR, IncResults of operations.−18.3%8-K 2.02 ↗
  28. COAGHemab Therapeutics Holdings, IncResults of operations.Expects to present data from the ongoing VELORA Pioneer Phase 1/2 trial of HMB-002 in Von Willebrand Disease at the 20th EAHAD (European Association for Haemophilia and Allied Disorders) Congress in…−8.2%8-K 2.02 ↗
  29. CTYCity Therapeutics, IncRegulation FD disclosure.City Therapeutics Announces First Participant Dosed in Phase 1 Clinical Trial of CITY-RBP4 for the Treatment of Stargardt Disease CITY-RBP4 is an RNAi therapeutic candidate designed to provide…8-K 7.01 ↗
  30. PDYNPalladyne AI CorpResults of operations and Regulation FD disclosure.Palladyne AI Reports Record Third Quarter 2026 Results Revenue increased 895% year-over-year and 48% sequentially to $8.6 million Raises bottom end of full-year 2026 revenue guidance to $25 million…−33.1%8-K 2.02 ↗
  31. CGEMCullinan Therapeutics, IncResults of operations.−24.2%8-K 2.02 ↗
  32. SIONSionna Therapeutics, IncResults of operations.−20.9%8-K 2.02 ↗
  33. UPBUpstream Bio, IncResults of operations.Upstream Bio Reports Third Quarter 2026 Financial Results and Highlights Continued Progress - Company plans to initiate Phase 3 trials in both severe asthma and CRSwNP in the first quarter of 2027 -…−55.6%8-K 2.02 ↗
  34. OLMAOlema Pharmaceuticals, IncResults of operations.−4.6%8-K 2.02 ↗
  35. MASS908 Devices IncResults of operations.908 Devices Reports Third Quarter 2026 Financial Results and Achieves Record Revenue Revenue increased 35% compared to prior year Raises low end of 2026 revenue outlook−24.7%8-K 2.02 ↗
  36. HUMAHumacyte, IncResults of operations.−2.2%8-K 2.02 ↗
  37. OVIDOvid Therapeutics IncResults of operations.−22.8%8-K 2.02 ↗
  38. IRDOpus Genetics, IncResults of operations.−5.0%8-K 2.02 ↗
  39. QBTSD-Wave Quantum IncResults of operations.D-Wave Reports Third Quarter 2026 Results Third Quarter Revenue Up 21% Year Over Year Remaining Performance Obligations of $38.3 Million Up 1,221% Year Over Year−43.2%8-K 2.02 ↗
  40. SUNESUNation Energy, IncRegulation FD disclosure.−15.8%8-K 7.01 ↗
  41. ENVAEnova International, IncOther events.ENOVA ANNOUNCES NEW $500 MILLION SHARE REPURCHASE PROGRAM−2.7%8-K 8.01 ↗
  42. LQDALiquidia CorpResults of operations and other events.+13.7%8-K 2.02 ↗
  43. REFIChicago Atlantic Real Estate Finance, IncResults of operations and Regulation FD disclosure.−5.1%8-K 2.02 ↗
  44. HBIOHarvard Bioscience IncRegulation FD disclosure.−4.7%8-K 7.01 ↗
  45. HBIOHarvard Bioscience IncResults of operations.Reaffirms Full Year 2026 Revenue Guidance of 3%-5% Year Over Year Growth−4.7%8-K 2.02 ↗
  46. JBIJanus International Group, IncResults of operations and Regulation FD disclosure.JANUS INTERNATIONAL GROUP REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS−31.3%8-K 2.02 ↗
  47. PLXProtalix BioTherapeutics, IncResults of operations.Cash, cash equivalents, and short-term bank deposits were $48.5 million as of September 30, 2026+12.8%8-K 2.02 ↗
  48. SBHSally Beauty Holdings, IncResults of operations and Regulation FD disclosure.−9.1%8-K 2.02 ↗
  49. NVANova Minerals CorpRegulation FD disclosure.Nova Minerals Confirms 216,000 tpa Processing Capacity, Advancing Alaska’s Critical Minerals Hub−54.8%8-K 7.01 ↗
  50. WYFIWhiteFiber, IncMaterial agreement and new debt or obligation.−33.6%8-K 1.01 ↗